Further to DrugAlert Volume 302, HPS Pharmacies wish to give notice that all suppliers are continuing to experience an interruption to the supply of norfloxacin 400mg tablets. Supplies of the active pharmaceutical ingredient are now also unavailable for compounding norfloxacin capsules. Normal supplies of norfloxaxin tablets are expected to resume in September 2017.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.